Adrenergic beta-Antagonists

All categories
DBCAT000456Therapeutic categoryS01ED

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. A DrugBank category of 42 drugs. 27 of them are approved.

ATC classification
Part of
Adrenergic Antagonists
Also known as
Adrenergic beta Antagonists · Adrenergic beta Receptor Blockaders · Adrenergic beta-Blockers · Adrenergic beta-Receptor Blockaders · Agents, beta-Adrenergic Blocking
Drugs

and 17 more with a free account

What you can answer from here — as of August 09, 2019

42DrugsEach linked to its full drug card
Sign in
41Drug targetsEvery drug–target pair in the class, with bond type
Sign in
10,936Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
11Routes of administrationHow the drugs in this class are given
Sign in
2SubcategoriesNarrower classes within this one
Sign in

Which targets do Adrenergic beta-Antagonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In